Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04089358 · ClinicalTrials.gov registry record · Phase 3

Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study

A Phase 3 study of Malignant Solid Neoplasm and Hematopoietic and Lymphoid Cell Neoplasm, sponsored by Children's Oncology Group.

Active
Registry status
Phase 3
Development phase
387
Enrollment target
20
Study locations

NCT04089358 is a Phase 3 study of Malignant Solid Neoplasm and Hematopoietic and Lymphoid Cell Neoplasm that is active but no longer recruiting, run by Children's Oncology Group. The registered enrollment target is 387 participants, below the 1,139-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (66% lower). The trial reports 20 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04089358, a Phase 3 study of Malignant Solid Neoplasm and Hematopoietic and Lymphoid Cell Neoplasm, is active but no longer recruiting, sponsored by Children's Oncology Group.

ACTIVE NOT RECRUITING
Registry status
Phase 3
Development phase
387 participants
Enrollment target
20
Study locations

Study Summary

This phase III trial compares a multi-component mobile health and social media physical activity intervention versus wearing a physical activity tracker alone among adolescent and young adult childhood cancer survivors. Regular physical activity helps maintain healthy weight, energy levels, and health. Adolescents and young adults who complete treatment for cancer are often less active. They may gain weight and have more health problems compared to people the same age who have not had treatment for cancer. Comparing the 2 programs will help researchers learn how to increase physical activity levels over time and also how changes in physical activity levels affect health and quality of life over time.

Interventions

  • OTHER Educational Intervention
  • OTHER Goal Setting
  • OTHER Media Intervention
  • OTHER Health Promotion and Education
  • DEVICE FitBit

Study Locations (20)

California

  • Kaiser Permanente Downey Medical Center - Downey
  • City of Hope Comprehensive Cancer Center - Duarte
  • Miller Children's and Women's Hospital Long Beach - Long Beach
  • Children's Hospital Los Angeles - Los Angeles
  • Mattel Children's Hospital UCLA - Los Angeles
  • Valley Children's Hospital - Madera
  • UCSF Benioff Children's Hospital Oakland - Oakland
  • Kaiser Permanente-Oakland - Oakland
  • Children's Hospital of Orange County - Orange
  • University of California Davis Comprehensive Cancer Center - Sacramento
  • Santa Barbara Cottage Hospital - Santa Barbara
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center - Torrance

Connecticut

  • Connecticut Children's Medical Center - Hartford
  • Yale University - New Haven

District of Columbia

  • MedStar Georgetown University Hospital - Washington D.C.
  • Children's National Medical Center - Washington D.C.

Alabama

  • USA Health Strada Patient Care Center - Mobile

Arizona

  • Banner Children's at Desert - Mesa

Delaware

  • Alfred I duPont Hospital for Children - Wilmington

Florida

  • Golisano Children's Hospital of Southwest Florida - Fort Myers

Trial Details

FieldValue
Enrollment Target 387 participants
Start Date 2020-12-07
Est. Completion 2026-06-30
Phase Phase 3

Sponsor

Children's Oncology Group

342 total trials

What the Registry Record Tells You About NCT04089358

The ClinicalTrials.gov registry entry for NCT04089358 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 387 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,139-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (66% lower). The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Educational Intervention is the first listed.

NCT04089358 reports 20 study locations spanning 7 distinct geographic areas - top geographies include California, Connecticut, District of Columbia.

Frequently Asked Questions

What is clinical trial NCT04089358 about?

NCT04089358 is a clinical study titled "Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study". This phase III trial compares a multi-component mobile health and social media physical activity intervention versus wearing a physical activity tracker alone among adolescent and young adult childhood cancer survivors. Regular physical activity helps maintain healthy weight, energy levels, and heal...

What is the current status of trial NCT04089358?

This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 387 participants. The study started on 2020-12-07. Estimated completion is 2026-06-30.

What conditions does trial NCT04089358 study?

This clinical trial studies the following conditions: Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm.

What interventions are being tested in trial NCT04089358?

The interventions under investigation include: Educational Intervention (OTHER), Goal Setting (OTHER), Media Intervention (OTHER), Health Promotion and Education (OTHER), FitBit (DEVICE).

Who is sponsoring clinical trial NCT04089358?

This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04089358 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Connecticut, Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.